Table 1 Demographic and clinical characteristics of patients with neuroblastoma, SEER 18
Variables | Categories | Cohort (%) | |
|---|---|---|---|
All NB patients (n = 4338) | SMN (n = 38) | ||
Sex | Male | 2294 (52.9) | 19 (50.0) |
Female | 2044 (47.1) | 19 (50.0) | |
Age at diagnosis (first primary) (years) | < 1 | 1493 (34.4) | 14 (36.8) |
1–5 | 2347 (54.1) | 18 (47.4) | |
6–19 | 498 (11.5) | 6 (15.8) | |
Year of diagnosis | 1973–1979 | 303 (7.0) | 5 (13.2) |
1980–1989 | 506 (11.7) | 18 (47.4) | |
1990–1999 | 750 (17.3) | 5 (13.2) | |
2000–2009 | 1739 (40.1) | 9 (23.7) | |
2010–2015 | 1040 (24.0) | 1 (2.6) | |
Primary Site | Abdomen | 3019 (70.7) | 24 (63.2) |
Thorax | 773 (18.1) | 10 (26.3) | |
Others | 478 (11.2) | 4 (10.5) | |
Histologic type | Neuroblastoma, NOS | 3667 (84.5) | 36 (94.7) |
Ganglioneuroblastoma | 671 (15.5) | 2 (5.3) | |
Race | White | 3410 (79.6) | 30 (78.9) |
Black | 528 (12.3) | 5 (13.2) | |
Other | 348 (8.1) | 3 (7.9) | |
Radiotherapy | Yes | 1085 (25.0) | 19 (50.0) |
No/unknown | 3253 (75.0) | 19 (50.0) | |
Chemotherapy | Yes | 2829 (65.2) | 28 (73.7) |
No/unknown | 1509 (34.8) | 10 (26.3) | |